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Abstract 
 
Proteins responsible for the integrity of the genome are often used targets in drug therapies against 
various diseases. The inhibitors of these proteins are also important to study the pathways in genome 
integrity maintenance. A prominent example is Ugi, a well known cross-species inhibitor protein of 
the enzyme uracil-DNA glycosylase, responsible for uracil excision from DNA. Here, we report that a 
Staphylococcus pathogenicity island repressor protein called StlSaPIbov1 (Stl) exhibits potent dUTPase 
inhibition in Mycobacteria. To our knowledge, this is the first indication of a cross-species inhibitor 
protein for any dUTPase. We demonstrate that the Staphylococcus aureus Stl and the Mycobacterium 
tuberculosis dUTPase form a stable complex and that in this complex, the enzymatic activity of 
dUTPase is strongly inhibited. We also found that the expression of the Stl protein in Mycobacterium 
smegmatis led to highly increased cellular dUTP levels in the mycobacterial cell, this effect being in 
agreement with its dUTPase inhibitory role. In addition, Stl expression in Mycobacterium smegmatis 
drastically decreased colony forming ability, as well, indicating significant perturbation of the 
phenotype. Therefore, we propose that Stl can be considered to be a cross-species dUTPase inhibitor 
and may be used as an important reagent in dUTPase inhibition experiments either in vitro/in situ or in 
vivo. 
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1. Introduction 
Proper control of the intracellular concentration of dNTPs is critically important for efficient and 
faithful DNA replication and genomic stability [1–3]. In fact, dNTP pool imbalances often cause 
mutator effects [4–7]. Due to the intriguing lack of a functional mismatch repair system in 
Mycobacteria, with potential important biological implications with respect to the evolution of 
mycobacterial genomes, mutator effects of nucleotide pool imbalances may have an increased 
significance [8]. The absence of mismatch repair in Mycobacteria can also indicate an elevated 
importance for the remaining DNA damage recognition and repair pathways in maintaining genomic 
integrity. These pathways include double-strand break repair as well as the preventive and the base 
excision repair (BER) mechanisms. Interestingly, Mycobacteria have evolved remarkable redundancy 
in their BER system. For example, M. tuberculosis harbours two MutM homologues responsible for 
excision of 8-oxo-guanin [9] and also two uracil DNA glycosylases [10]. Both MutM and uracil DNA-
glycosylases are important in oxidative stress response. 
Preventive DNA repair relies on dNTP pool sanitizing pathways, among which dUTPase enzymes 
catalyse pyrophosphorolysis of dUTP generating dUMP and inorganic pyrophosphate [3,11,12]. This 
reaction is of key importance since dUTP is constantly produced in the pyrimidine biosynthesis 
pathways and most (including mycobacterial) DNA polymerases readily incorporate dUMP into DNA 
as a dTMP replacement if the cellular dUTP pool is elevated. DNA uracilation under high dUTP pool 
conditions will lead to hyperactive futile cycles of base-excision repair and decreases viability by 
disrupting genome integrity [13]. To prevent DNA uracilation, dUTPase is required to eliminate 
excess dUTP. In addition, the product dUMP is the precursor for dTTP biosynthesis. The homotrimer 
dUTPase enzymes have three active sites, each constituted by conserved sequence motifs (motif I-V) 
from all three subunits [14–18]. In mycobacterial genomes, a bifunctional dCTP deaminase:dUTPase 
is additionally encoded [19]. This enzyme shows a very similar homotrimeric fold and catalyses both 
the dCTP deamination reaction and the triphosphate hydrolysis of the resulting dUTP, directly 
producing dUMP from dCTP. However, the efficiency of the triphosphate hydrolysis by the 
bifunctional enzyme is several hundred fold less [19] than that of the monofunctional trimeric 
dUTPase [20].The monofunctional dUTPase (dut) is essential in Mycobacteria [21–23]. In contrast, 
earlier mutagenesis studies found that the presence of the bifunctional dCTP deaminase:dUTPase 
enzyme is dispensable for growth in M. tuberculosis [21,22]. 
The Mycobacteria genus comprises highly challenging pathogens including Mycobacterium 
tuberculosis and Mycobacterium leprae, the causative agents of tuberculosis and leprae, respectively. 
These pathogens still remain a public health problem worldwide despite extensive research and drug 
development efforts. Since dUTPase plays an important role in genom integrity maintenance and is 
essential in M. tuberculosis, it may serve as an effective drug target for developing novel drug 
4 
 
candidates [24,25,20,26]. In addition to attempts in identification of small molecule inhibitors, highly 
potent proteinaceous inhibitors can be also very useful in studying the role and function of the target 
protein in the living cell. Proteinaceous inhibitors can be expressed under different conditions and 
provide versatile and revealing tools for the investigation of various cellular pathways. In this respect, 
it is worthwhile to point out that the function of the uracil-DNA glycosylase (Ung) enzyme, 
responsible for uracil excision from DNA, can be readily inhibited by a widely characterized and 
generally used inhibitor protein (Ugi) in different in vitro/in vivo experiments [27–29]. However, as of 
present, there is no such report on a general inhibitor protein for dUTPases. Although the presence of 
potential dUTPase inhibitor proteins in Bacillus subtilis and Drosophila melanogaster was suggested 
in the early literature [30,31], till now none of these suggestions could be confirmed at the molecular 
level. However, it was recently shown that a pathogenicity island repressor protein in Staphylococcus 
aureus, StlSaPIbov1 (Stl), is capable of interacting with the helper phage dUTPase and that the Stl 
repressor activity is inhibited in the complex [32,33]. Detailed quantitative characterization of this 
interaction also revealed that the Stl repressor is a highly potent protein inhibitor of the 
Staphylococcus aureus phage Φ11 dUTPase, as well [33].  
Here, we aimed to investigate if Stl acts as a dUTPase inhibitor in a highly unrelated species, we 
designed in vitro binding and inhibition experiments with Mycobacterium tuberculosis dUTPase 
(mtDUT). The positive outcome of these experiments inspired the in vivo study of Stl expression in 
the Mycobacterium smegmatis (M. smegmatis) cell. 
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2. Materials and methods 
2.1. Bacterial strains, media and growth conditions  
M. smegmatis mc2155 was grown in Lemco medium (broth) or with the addition of 15 g L-1 Bacto agar 
(solid). Gentamycin was added at 10 µg/ml and hygromycin B at 100 µg/ml final concentration. 
2.2. Expression and purification of Stl protein 
For expression of Stl, Escherichia coli BL21(DE3) pLysS cells transformed with pGEX-4T-1vector 
containing Stl-GST fusion protein [33] were propagated in 500 ml LB to an OD600 of 0.6, then the 
culture was cooled to 30 oC and than induced with 0.5 mM iso-propyl-β-D-thiogalactoside. After 
induction, the cell cultures were grown for a further 4 h at 30 oC. Finally the cells were harvested by 
centrifugation. Subsequent manipulations were carried out on ice. For purification of Stl protein, cell 
pellets were solubilized in 15 ml of buffer A (PBS (pH 7.3), 5mM MgCl2) supplemented with 400 mM 
NaCl, 2 mM dithiothreitol (DTT), 1% Triton X-100, 2 µg/ml RNase and Dnase and one tablet of 
cOmplete ULTRA Tablets, Mini, EDTA-free protease inhibitor. Cell suspensions were stirred for 10 
min, sonicated (4 x 60 s), and centrifuged (16000 g for 30 min). Supernatant was diluted in buffer A to 
contain 200 mM NaCl and loaded on a preequlibrated benchtop glutathion-agarose affinity-
chromatography column. The column was washed with ten volumes of buffer A (200 mM NaCl). 
After that, 80 Cleavage Unit thrombin was added to perform on-column cleavage for the removal of 
glutathion-S-transferase tag. After overnight cleavage, Stl protein was eluted from the column (at 
>95% purity, as estimated from SDS-PAGE). Stl protein was stored in 400 mM NaCl to obtain 
suitable protein stability.  
2.3. Expression and purification of dUTPase 
Recombinant dUTPases (wild type M. tuberculosis dUTPase (mtDUTwt) and the point mutant enzyme 
conferring a single Trp in the active site (mtDUTH145W)) carrying an N-terminal hexa-His tag were 
expressed from pET19-b vector in Escherichia coli BL21(DE3) pLysS cells [20]. For protein 
overexpression, the cells were grown to an OD600 of 0.4, treated with 0.5 mM isopropyl-b-D-
thiogalactopyranoside at 37oC for 3 hours. Protein purification was carried out as described previously 
[20]. The final supernatant after cell extraction was loaded on a Ni-NTA column (Novagen) and 
purified according to the Novagen protocol. The purity of the protein preparation was analyzed by 
SDS-PAGE.  
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2.4. Steady-state colorimetric dUTPase assay 
Protons released in the dUTPase reaction were detected by phenol red pH indicator in 1 mM HEPES 
pH 7.5 buffer also containing 150 mM KCl, 40 µM phenol red (Merck) and 5 mM MgCl2 [34–37]. A 
Specord 200 (Analytic Jena, Germany) spectrophotometer and 10 mm path length thermostated 
cuvettes were used at 20oC. Absorbance was recorded at 559 nm. Initial velocity was determined from 
the slope of the first 10% of the progress curve. For the determination of the apparent Ki of Stl 
inhibition reaction mixtures contained 50 nM enzyme and varying concentrations of Stl. Reaction was 
started with the addition of 30 µM dUTP after 5 minutes preincubation of the two proteins. Stl 
inhibition data were fitted to the quadratic binding equation describing 1:1 stoichiometry for the 
dissociation equilibrium with no cooperativity: 
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where x is the Stl concentration and y is the relative enzyme activity (normalized to the uninhibited 
activity), s=y at x=0, A is the total amplitude of the activity change, c is the enzyme concentration and 
Ki is the apparent inhibition constant of Stl inhibition. 
For the determination of Michaelis-Menten parameters of dUTPase in the absence and presence of Stl 
reaction mixtures contained 50 nM enzyme, 150 nM Stl and varying concentration of dUTP. Reaction 
was started with the addition of dUTP after 5 minutes preincubation of the two proteins. Michaelis-
Menten equation was fitted to the initial velocity data. Data were analyzed in Origin 8.5 (OriginLab 
Corp., Northampton, MA). 
2.5. Native Gel Electrophoresis 
Native gel electrophoresis was performed in 8% polyacrylamide gel, which was pre-equilibrated with 
pH 8.7 Tris-HCl buffer for 30 mins with constant voltages of 100 V. Then 20 µl of samples were 
added to each well and the electrophoresis was performed for 2.5 hours at 150 V. Sample 
concentrations are indicated. During electrophoresis the apparatus was cooled on ice. The gel was 
stained with Coomassie-Brilliant Blue dye.  
2.6. Construction of Stl expressing M. smegmatis strains 
The strong promoter of Kanamycin gene from p2NIL plasmid [38] was PCR-amplified and cloned 
into the vector pGem-T-easy (Promega). The Gm-Int HindIII cassette from the pUC-Gm-Int plasmid 
[38] was introduced into the resulting construct to yield the integrating vectorpGem-int-empty (used as 
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control). The Stl coding region with AU1-tag was PCR-amplified from pGEX-4T-1 expression vector 
(generated in [33]) and cloned after the promoter (ending in NheI restriction site) in the vector pGem-
int-empty with NheI restriction sites to get pGem-int-Stl. Successful cloning was verified with 
sequencing of the appropriate region of the plasmid. 0.5-0.5 µg of pGem-int-Stl and pGem-int-empty 
(used as control) were electroporated into electrocompetent wt M. smegmatis strain. Three parallel 
strains from each were chosen and used in the experiments. Primers used for cloning are compiled in 
Table S1. 
2.7. Construction of inducible Stl expressing M. smegmatis strains 
The Stl coding region with AU1-tag from pGEX-4T-1 was pcr-amplified and cloned into the vector 
pKW08-Lx [39] (Addgene) in place of the Lx gene with using BamHI and HindIII restriction sites. 
Successful cloning was verified with sequencing of the appropriate region of the plasmid. 0.5-0.5 µg 
of pKW08-Stl and pKW08-Lx (used as control) were electroporated into electrocompetent wt M. 
smegmatis strain. Three parallel strains from each were chosen and used in the experiments. Primers 
used for cloning are compiled in Table S1. 
2.8. Verification of protein expression by Western blot 
Stl expressing M. smegmatis strains were grown until the OD600 reached 0.4–0.5 then the cells were 
harvested by centrifugation. Pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH= 7.5; 140 
mM NaCl; 1 mMEDTA; 0.5% SDS; 1% Triton X-100; 0.5 mM PMSF; 2 mMBA; 15 mM 2-
mercaptoethanol; 0.1 mg/ml DNase) and sonicated (Elma, S30H ElmaSonic, D78224) for 4 times 5 
minutes. Concentrations of the final supernatants of the cell extraction were measured using Nanodrop 
ND-1000 and equalized by dilution before Western-blot analysis. Protein lysates were heated at 
95oCfor 5 min, separated by SDS-PAGE, and transferred to PVDF membrane for immunoblotting with 
the specific antibody against AU1 epitope-tag (Novus Biologicals). Immune-complexes were 
visualized using enhanced chemiluminescence. The blotted polyacrylamide gel stained with 
ComassieBrilliant Blue and the PVDF membrane stained with Ponceau were used as loading controls. 
2.9. dNTP extraction 
Exponential phase cells were grown with appropriate antibiotics until OD600 = 0.6. The total CFUs 
were determined for each culture, and cells were centrifuged for extraction. Washed pellet were 
extracted in 0.5 ml ice-cold 60% methanol overnigth at -20 °C. Cells were removed by centrifugation 
(15-20 min, 13000 rpm) the methanolic supernatant was boiled for 5 min and centrifuged. Soluble 
dNTP fraction containing supernatant were evaporated under vacuum (Eppendorf) at 45 °C, 1 h. 
Extracted dNTPs were dissolved in 50 µl dUTPase puffer (30 mM Tris-HCL, pH 7.5, 10 mM MgCl2, 
50 mM NaCl, 1 mM EDTA) and stored at -80 °C. 
8 
 
2.10. Determination of the pyrimidine pool size 
Determination of the dCTP and dTTP pool size in each extract was based on DNA polymerase-
catalyzed incorporation of radioactive dNTP into synthetic oligonucleotide templates [40]. The 
reaction mixture (50 µL) contained Klenow buffer, 0.5 unit exonuclease negative Klenow-fragment 
(Fermentas), 0.25 µM dTTP/dCTP specific template, 0.25 µM primer (Table S1), 8 µl dNTP-extract 
2.5 µM [3H] dATP (1,5 Ci/mmol) (American Radiolabeled ChemicalsInc.). Incubation was carried out 
for 60 min at 37°C and reaction mix was spotted onto DE81 paper. The papers were dried, washed (3 
× 10 min) with 5% Na2HPO4, and rinsed once with distilled water and once with 95% ethanol. After 
drying, radioactivity on the papers was measured in a liquid scintillation counter (Beckman). In case 
of dCTP measurement we used Taq polymerase, (RedTaq, Sigma), as Klenow polymerase is capable 
of incorporating CTP and GTP from nucleotide extracts [41]. Incubation was carried out at 48°C for 1 
hour. Two-fold dilution series were prepared from cell extracts in the PCR reactions. Three parallel 
strain were used from each mutation in the experiments. 
2.11. Determination of the dUTP pool size 
dUTP concentration was measured according to Koehler et al. [42]. The samples used for 
dTTP measurements were distributed into two equal portions. The first portion was treated 
with 40 ng recombinant dUTPase (mtDUTH145W) [20] at 37 °C, 45 mins, then dUTPase 
enzyme was precipitated with 60% methanol. Therefore, in the first portion, dUTP was 
hydrolyzed while in the second portion (not treated with dUTPase) both dTTP and dUTP 
remained present. The dUTP and dTTP levels were calculated as follows: dUTP = dTTPnon-
treated – dTTPtreated; dTTP = dTTPtreated. 
2.12. Genomic DNA isolation 
10 mL liquid culture was grown until OD600 of 0.5 and harvested. The cells were resuspended in 1 mL 
10 mM Tris, pH 7.5 and 0.1 mm glass beads were added to 2 mL volume. The cells were disrupted by 
vortex and ice incubation by turn. After centrifugation the supernatant was manipulated routinely to 
purify DNA by phenol:chloroform:IAA (25:24:1) extraction followed by isopropanol precipitation. 
2.13. Determination of genomic uracil content 
In order to quantify uracil content of DNA, a real-time quantitative PCR-based assay was used [43]. 
Genomic DNA was isolated and digested with BamHI. DNA fragments of 5 kb were purified from gel 
for enrichment of specific fragments. Real-time PCR was performed on Mx3000P qPCR System 
(Agilent Technologies) using EvaGreen dye (Biotium) and PfuTurbo Hotstart DNA polymerase 
(Stratagene) or Mytaq Hotstart DNA polymerase (Bioline). A segment with 1017 base length defined 
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by the primers (Table S1) is amplified during the PCR reaction. As described previously, the detection 
limit of this method is around 100 uracil/million bases when the PCR template used is of approx. 1000 
bases [43]. Two-fold dilution series were prepared from DNA samples. Three parallel strain were used 
from each mutation in the experiments. 
2.14. Growth inhibition test 
Mycobacterium smegmatis strains were growed in liquid media until saturation and induced with 20 
ng/ml Tetracyclin. 10 fold dilution series were plated after 0, 1, 2, 4, 8 and 24 hours of induction. CFU 
was counted and normalized to t=0. Three parallel strains and controls were used in the experiments. 
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3. Results 
3.1. Stl binds to M. tuberculosis dUTPase in vitro 
Previous studies showed that Stl is capable to form a complex with Staphylococcus aureus phage Φ11 
dUTPase [33]. To investigate whether Stl may also bind to mycobacterial dUTPase (mtDUT), we 
carried out native gel electrophoresis experiments. As shown on Figure 1A, when the mixture of the 
two proteins is run on the gel, we can only observe a very slight, if any, band corresponding to the 
positions of the free proteins, however, a new band appears putatively corresponding to the complex 
of these two proteins. These results clearly suggest that mtDUT and Stl form a stable complex. 
Complexation is most evident at 1:1 ratio of Stl and mtDUT subunits. 
3.2. Stl inhibits the enzymatic activity of M. tuberculosis dUTPase in vitro 
We have previously found that Stl inhibits the enzymatic acitivy of Staphylococcus aureus phage Φ11 
dUTPase [33]. The results suggested a slow and tight binding interaction between Stl and dUTPase. It 
was also shown that Stl and dUTP compete for the active sites of dUTPase. We designed in vitro 
experiments with mtDUT to investigate whether Stl can also inhibit this mycobacterial enzyme. We 
tested the Stl inhibition on the wild type enzyme (mtDUTWT) and on the quasi wild type variant 
(mtDUTH145W) containing a tryptophan substitution at the active site [20,44]. The active site 
architecture of dUTPase is well-known from the literature [45–48]. The mutated position is conserved 
for aromatic residues. The conserved Phe/ Tyr/ Trp at this position stacks over the uracil ring of the 
substrate that contributes to the catalytic efficiency of dUTPase reaction [44]. Aromatic substitution at 
this position does not alter the mechanism of action [49]. 
In both cases, a very strong inhibition of dUTPase enzymatic activity exerted by Stl was observed 
(Figure 1B). Both kcat and KM values were changed as a result of Stl inhibition, indicating a mixed 
kinetic mechanism of inhibition that may suggest allosteric behavior. However, further kinetic 
experiments are required for an in-depth characterization of the mechanism of inhibition, these will 
form the basis of a further study. Similarly to the measurements with Φ11 dUTPase, Stl inhibition is 
only observed in case the dUTPase variants are pre-incubated with Stl before dUTP addition. This 
indicates that the formation of the mtDUT:Stl complex is slow as compared to substrate binding (cf. 
[33]). Results of a titration experiment with varying Stl concentration indicated that the inhibitory 
effect of Stl is associated with a very low apparent inhibitory constant (Ki in the nanomolar range, Fig 
1B, Table I.). This Ki value is on the same low range as found in the case of the Stl-induced inhibition 
experiments of the S. aureus phage Φ11 dUTPase [33], suggesting that the complexation of Stl with 
the two dUTPases are similarly strong. However, the maximal inhibition is about 80 %, which value is 
somewhat lower as compared to the Φ11 dUTPase (100 %) (Figure 1B, Table I.).  
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We also tested the substrate concentration dependence of dUTPase activity in the presence and 
absence of Stl. These results show that the maximal activity of both mycobacterial dUTPases (wild 
type and Trp mutant) decreases in the presence of Stl with practically same characteristics, while the 
Michaelis constant (KM) increases (Figure 1C, Table I.). These parametric changes, together with the 
low Ki for Stl:mtDUT compared to the KM for mtDUT:dUTP and the relevant observation of the 
requirement for pre-incubation suggest a slow and tight binding inhibition mechanism, as it was 
observed for Φ11 dUTPase [33]. However, the lower value of the maximal inhibition (80 % versus 
100 %) may indicate a difference in the nature of the interaction between the substrate and the 
dUTPase:Stl complex for mycobacterial and Φ11 dUTPases – this difference will be investigated in 
forthcoming studies. 
Our results also show that the tryptophan substitution at the active site in mtDUTH145W does not change 
the interaction of Stl with dUTPase. This finding will facilitate more detailed biochemical 
characterization of the mtDUT: Stl interaction with the help of the intrinsic tryptophan label in later 
studies.  
3.3. Stl expression causes increased dUTP level in M.smegmatis 
To investigate whether Stl can inhibit the dUTPase function in the Mycobacterium cell, we 
constructed M. smegmatis strains that expressed the Stl protein from the pGem-int-Stl plasmid 
integrated to the M. smegmatis genome. The expression of the AU-1 tagged Stl protein in the 
transformed strains was verified with Western-blotting (Figure S1). We have determined pyrimidine 
nucleotide levels in cell extracts by a PCR-based method [40] and found that the levels of dTTP and 
dCTP were normal. However, the level of dUTP was significantly increased in the Stl expressing 
strains compared to control strains transformed with an empty vector (Figure 2A). Potential increase in 
the genomic uracil content in the Stl expressing strains remained below the detection limit. 
3.4. Stl expression perturbs colony formation in M. smegmatis 
We also constructed a strain in which we could express the Stl protein in a tetracyclin-inducible 
manner to exclude any compensatory effect for growth. We constructed this strain by electroporating 
electrocompetent wild type M. smegmatis cells with pKW08-Stl. The tetracyclin-inducible expression 
of AU-1 tagged Stl protein in the transformed strains was verified with Western-blotting (Figure 3A). 
Stl expression was observed after 1 hour of induction and was clearly visible after 8 hours of 
expression upon the addition of 20 ng/ml tetracyclin (Figure 3A). Without tetracyclin induction, the 
basal transcription level seemed to be lower than that in the 1-hour post-induction sample. We found 
that upon induction of Stl expression, the ability of colony formation was drastically decreased (the 
number of colony-forming units (CFU) remained constant) as compared to the control strains in which 
luciferase (Lx) expression was induced (transformed with pKW08-Lx) [39] (Figure 3B). Consistently, 
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we also found much less colonies after the electroporation of 0.5 µg pGem-int-Stl into 
electrocompetent M. smegmatis as compared to the the control case (data not shown). 
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4. Discussion 
The uracil-DNA glycosylase inhibitor (Ugi) protein, isolated from the Bacillus subtilis bacteriophage 
PBS2, is a well known and generally used inhibitor of the Ung enzyme from various species 
[28,29,50,51]. Although the presence of potential dUTPase inhibitor proteins was also suggested in 
bacteriophage PBS2 infected B. subtilis cells as well as in Drosophila melanogaster cell extracts 
[30,31], till now none of these suggestions could be confirmed at the molecular level. Here we show 
that Stl, a repressor protein of Staphylococcus aureus is not only a potent inhibitor of the 
Staphylococcal Φ11 phage dUTPase [33], but also exerts cross-species effects by inhibiting 
mycobacterial dUTPases both in vitro and in the bacterial cell. 
Results presented in Figure 1 show that Stl and M. tuberculosis dUTPase form a stable complex and 
that in this complex, the enzymatic activity of dUTPase is strongly inhibited. We also found that the 
expression of the Stl inhibitor protein led to high cellular dUTP levels and moderate colony forming in 
M. smegmatis cells (Figures 2 and 3). However, Stl expression did not perturb the cellular levels of 
other pyrimidine nucleotides (ie. dCTP and dTTP). In a recent study, we showed that a mycobacterium 
specific structural motif is essential for viability potentially due to a yet unidentified protein-protein 
interaction [23]. This putative interaction was most likely not perturbed by Stl, as the bacteria 
expressing the exogenous inhibitor protein remained viable, although colony formation was decreased. 
We also measured the genomic uracil content of the Stl expressing strains but could not detect 
significant increase. Hence, most of the dUMP moieties incorporated into DNA under the high cellular 
dUTP concentration environment could have been repaired by the uracil excision repair enzymes. In 
addition to the usually present uracil-DNA glycosylase enzymes, Mycobacteria encode an additional 
uracil DNA glycosylase (UdgB) [52,53], potentially facilitating efficient repair. 
Although the lack of conventional mismatch repair (MMR) and the presence of error prone 
polymerases present clear variableness which may denote evolutionary advantage for Mycobacteria 
[8], our result on colony forming ability upon Stl expression indicates that the preservation of the 
normal nucleotide pool and genomic integrity is of high importance in Mycobacteria. The presence of 
multiple enzymes with similar functions in preventive DNA repair mechanisms and in the base 
excision repair (ie. two dUTPases (dUTPase and a bifunctional dCTP deaminase/dUTPase) and two 
uracil DNA glycosylase enzymes) also indicates the importance of these pathways. According to our 
in vitro results, we expect about 20% of the dUTPase activity remaining in the Stl-expressing 
mycobacterial cell and still, we detected a clear phenotype (ie. increasing dUTP level and decreased 
colony formation) in contrast with almost complete inhibition of dUTPase by siRNA in human cells 
where such inhibition had no detectable effect on the cellular phenotype only in the additional 
presence of FdUrd [54,55]. 
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According to our results we propose Stl as a reagent to be used in dUTPase inhibition experiments 
either in vitro or in situ/in vivo in a manner analogous to experiments using Ugi as the inhibitor of Ung 
from various species. Several small molecule inhibitors against human dUTPase were recently 
published [56–59]. We, however, propose that proteinaceous inhibition of dUTPase is also possible 
and produces a clear cellular phenotype in Mycobacterium. The use of the exogenously expressed Stl 
protein in Staphylococcus and Mycobacteria is expected to become an effective tool in studying 
nucleotide metabolism pathways within the cellular environment. It remains to be seen if Stl may also 
inhibit eukaryotic dUTPases, as well. 
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Figure legends 
Figure 1. Stl forms a stable complex and inhibits Mycobacterium tuberculosis dUTPase in vitro 
A) Native gel electrophoresis experiment indicates stable complex formation between Stl and 
MtdUTPase. Species and concentrations given in monomers are indicated. B) Representative 
measurements of Stl’s inhibitory effect on mtDUTWT and on mtDUTH145W activity. To ensure 
comparability data were normalized to the uninhibited activity of the two dUTPase variants. The 
concentration of dUTPases and dUTP were 50 nM and 30 µM, respectively. Data were fitted using the 
quadratic binding equation (Equation 1) to yield apparent Ki = 5.5 ± 4.6 nM for mtDUTWT and 
apparent Ki = 4.4 ± 2.8 nM for mtDUTH145W. The total amplitudes of the activity change were 83.8 ± 
6.7 % for mtDUTWT and 87.1 ± 5.8 % for mtDUTH145W, respectively. Figure shows a representative 
measurement and its analysis. Errors shown are the errors calculated in the fitting process. Each 
measurement was repeated multiple times. The averages and the SD-s of these measurements are 
summarized in Table I. C) Representative measurements of substrate dependence of mtDUTWT 
activity in the presence and absence of 150 nM Stl. The concentration of dUTPase was 50 nM in the 
measurements. Smooth lines represent the fit of Michaelis-Menten equation to the data, yielding KM = 
1.4 ± 0.3 µM and kcat= 3 ± 0.1 1/s in the absence of Stl, KM = 9.7 ± 2.5 µM and kcat= 1.7 ± 0.1 1/s in 
the presence of 150 nM Stl. Figure shows a representative measurement and its analysis. Errors shown 
are the errors calculated in the fitting process. Each measurement was repeated multiple times. The 
averages and the standard deviations of these measurements are summarized in Table I. D) 
Representative measurements of substrate dependence of mtDUTH145W activity in the presence and 
absence of 150 nM Stl. The concentration of dUTPase was 50 nM in the measurements. Smooth lines 
represent the fit of Michaelis-Menten equation to the data, yielding KM = 1.3 ± 0.4 µM and kcat= 0.7 ± 
0.0 in the absence of Stl, KM = 5.3 ± 0.4 mtDUTH145W and kcat= 0.2 ± 0.0 in the presence of 150 nM Stl. 
Figure shows a representative measurement and its analysis. Errors shown are the errors calculated in 
the fitting process. Each measurement was repeated multiple times. The averages and the standard 
deviations of these measurements are summarized in Table I. 
Figure 2. Stl expression leads to an increased dUTP level in Mycobacterium smegmatis 
Pyrimidine nucleotide pool data measured in Mycobacteria either expressing or not expressing Stl 
protein. dTTP, dCTP and dUTP were measured with a PCR-based method. dUTPase treatment allows 
to differentiate between dUTP and dTTP. dTTP values shown are corrected with dUTP level measured 
in the sample. Three parallel strain were used in the experiments from both Stl expressing pGem-int-
Stl transformed bacteria (labeled as ’stl’) and both empty vector transformed bacterium (labeled as 
’wt’). Means±SE are plotted.  
Figure 3. Stl expression interferes with colony formation in Mycobacterium smegmatis  
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A) Expression of AU-1 tagged Stl after induction with tetracyclin in different time points (0, 1, 2, 4, 8 
and 24 hours after induction). ’C’ indicates constant Stl expression from pGem-int-Stl vector, ’M’ 
indicates protein marker and ’-’ indicates negative control. B) Colony-forming unit (CFU) counts after 
various period of induction of Stl expression. CFU counts were normalized to t=0. Three parallel 
strains were used in the experiments; means ± SE are plotted. 
 
 
Table I. Kinetic parameters of dUTPase inhibiton by Stl 
Michaelis-Menten 
parameters 
KM (μM) kcat (s
-1
) Number of 
repeats 
mtDUT
WT
 1.3 ± 0.1 2.6 ± 0.6 2 
mtDUT with Stl 9.4 ± 4.1 1.3 ± 0.3 4 
mtDUT
H145W
 1.6 ± 1.2 0.8 ± 0.2 3 
mtDUT
H145W 
with Stl 5.7 ± 0.9 0.3 ± 0.0 3 
Stl inhibition Ki (nM) Inhibition  
mtDUT
WT
 6.8 ± 4.4 81.1 ± 10.2 % 3 
mtDUT
H145W
 4.2 ± 0.8 85.2 ± 1.5 % 3 
 
Protein concentrations were as follows: mtDUT
WT 
or mtDUT
H145W
 : 50 nM, Stl : 150 nM. Further 
increase of Stl concentration did not cause any additional changes. Data represent average and 
standard deviations of parallel measurements.  
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